Clinical Documentation and Record Keeping
Records that hold up when someone else reads them: what to write, consent and refusal, labelled late entries, template pitfalls, reports, sick notes, retention and keeping the file intact.
Choose your country edition
New Zealand United States Canada Singapore United Arab Emirates All countriesPatient safety and medicines
Controlled medicines course for UAE prescribers and pharmacists: narcotics, psychotropics, the e-platform, supply limits and diversion
Physicians, dentists, pharmacists, nurses, midwives and other licensed professionals who prescribe, dispense, store or administer controlled medicines in any emirate, including those facing a complaint, audit or inspection finding.
Structured learning and a written reflection to show insight after a complaint, an investigation or a licensing authority inquiry.
Focused learning on a core standard of practice, with a certificate and reflection for your portfolio.
A habit that was routine in your previous country can be a violation in the UAE. A benzodiazepine prescribed outside your specialty, a supply period longer than your tier allows, a register entry made the next morning, a colleague's login used during a busy shift: each of these has led to complaints, audits and disciplinary action here. This course explains the rules that sit behind controlled medicines in the UAE, including Federal Decree-Law No. (30) of 2021 on combating narcotics and psychotropic substances, Federal Decree-Law No. (38) of 2024 on medical products, pharmacists and pharmaceutical establishments, the prescribing duties in Federal Decree-Law No. (4) of 2016, and the Unified Electronic Platform for Controlled Medications.
It then works through the full chain from decision to administration: how medicines are classified as CDa, CDb, prescription-only, pharmacist-only or over the counter, and how to check a product's current class; the limits on which clinicians can prescribe narcotic and psychotropic medicines, and DOH supply caps by prescriber tier; examination, clinical need, off-label use and telehealth; complete prescriptions and correct use of the platform; pharmacy legal and clinical checks, records, storage and discrepancies; safer use of opioids and sedatives; travellers and cross-border prescriptions; and recognising misuse, diversion and impairment in patients and in colleagues.
The course is aimed at physicians, dentists, pharmacists, nurses, midwives and other licensed professionals in Dubai, Abu Dhabi, Sharjah and the Northern Emirates. It suits clinicians new to the UAE, experienced prescribers wanting a current review, and anyone who has had a complaint, an audit finding, a DHA or DOH inspection report or a warning about controlled medicines. Dubai's Executive Council Resolution No. 49 of 2024 lists misuse of narcotic, controlled and semi-controlled prescriptions as a violation, so the final section explains how these concerns are investigated and how a targeted remediation plan and reflective account can help you show safer practice.
Controlled-medicine concerns in the UAE usually arrive with data attached: a platform alert, a pharmacist's report, a stock discrepancy or an audit of your prescribing pattern. A committee or licensing authority will want to see that you understand which rules you broke, why the habit made sense at the time and what checkable controls you now use. This course helps you show exactly that, from prescriber tiers and supply limits to personal credentials on the unified platform and safe review of opioids and sedatives.
The certificate records two hours (estimated) on safe prescribing and controlled medicines and the date you completed them. The reflective account, written under four headings, links the concern to specific changes, such as a review date on every controlled prescription or a personal monthly audit of platform data. That gives an employer or committee something they can verify. Where criminal law may be engaged, take advice from a UAE lawyer or your insurer before you respond.
What you will have at the end
A repeat benzodiazepine and a colleague's login
Consider, for illustration, a general practitioner who has recently moved from abroad to an urgent care clinic in Sharjah. A regular patient asks for a repeat supply of a benzodiazepine first prescribed overseas. Used to issuing longer supplies at home, the doctor prescribes beyond the period allowed for his grade. During a busy evening a colleague, whose credentials have expired, asks to use his platform login to issue another prescription.
Weeks later the unified platform flags an unusual pattern. A community pharmacist has also reported that the patient presented similar prescriptions at several pharmacies. The authority opens an investigation, and the doctor is surprised to learn that the shared login makes him answerable for prescriptions he never wrote. What felt like routine help to a patient and a colleague has become a disciplinary and potentially criminal matter.
The course addresses each step. Section 1 explains classification and why to check the list, not memory. Section 2 covers who may prescribe and how to handle requests outside your tier. Section 3 deals with supply limits and personal platform credentials. Section 6 helps spot misuse and diversion, and Section 7 explains how concerns are investigated and how to build a credible remediation plan.
Illustrative example, not a real case.
10 sections · 24 lessons · 2 hours (estimated) · 20-question final assessment
Final assessment
20scenario-based questions
Certificate of completion
A certificate of completion for your learning portfolio.
The course includes a structured reflective account template: guided prompts to record what you learned, how you will apply it and how the change will show in your practice. It gives you written evidence of insight after a concern, and a ready record for your CPD portfolio.
Write it in your own words and leave out anything that could identify a patient, a colleague or a case. If you have an open complaint or case, talk to your adviser before reflecting on it in writing.
CDa covers narcotic and psychotropic medicines under the strictest controls; CDb covers semi-controlled medicines with their own prescribing and recording rules. Classification can change, so Section 1 shows how to check a product's current class rather than relying on memory or on how it was handled in another country.
No. The narcotics law and emirate standards restrict who may prescribe narcotic and psychotropic substances and for how long, and the DOH sets supply limits by prescriber tier. Lesson 2.1 explains these conditions and how to stay within your privileges and specialty.
The Unified Electronic Platform for Controlled Medications is the national system for these prescriptions, and mistakes in using it often show up in audits. Lesson 3.2 covers access, prescribing steps, never sharing credentials and what to do when the system is unavailable.
Work through a structured legal and clinical review before dispensing, contact the prescriber, record the outcome and refuse where the law requires it. Section 4 sets out pharmacy duties under the narcotics and medical products laws, register keeping, storage and how to handle discrepancies.
It is designed for that situation. Section 7 walks through how a prescribing concern is looked into, the interim measures and penalties that can follow, and a remediation plan anchored in prescribing audits and supervision. Completing it can help you show insight and change; the weight given to it rests with your licensing authority.
Yes. Section 6 covers warning signs of misuse and diversion, talking to patients without stigma, what the narcotics law says about confidentiality and seeking treatment voluntarily, and what to do if you are concerned about a colleague's impairment.
Roughly 2 hours of online study, with a 20-question scenario-based assessment (80% to pass). Your certificate shows 2 hours (estimated). Your licensing authority decides how any learning counts towards your CPD or a requirement it has set.
Every legal and regulatory point comes from primary sources: UAE federal health laws, the licensing authorities' codes, standards and policies, and official government guidance. Anything we cannot confirm is left out.
Lessons, scenarios and assessment questions are written by us for each edition separately, then checked for accuracy, teaching quality and fair assessment before publication.
When a code, standard or law changes, the affected courses are reviewed and updated. Reported errors in legal or regulatory facts are corrected first.
Records that hold up when someone else reads them: what to write, consent and refusal, labelled late entries, template pitfalls, reports, sick notes, retention and keeping the file intact.
Licensed scope and privileges, supervision and delegation, CPD and gaps in practice, human factors, the deteriorating patient and sepsis, infection control and incident reporting in UAE facilities.
Honesty in licensing and CPD claims, records and late entries, sick leave certificates and reports, conflicts of interest, referral commissions, research and advertising.